EDGAR Filing Documents for 0001615774-17-000348

Form 8-K - Current report:

SEC Accession No. 0001615774-17-000348

Filing Date

2017-02-03

Accepted

2017-02-03 06:17:41

Documents

Period of Report

2017-02-01

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	s105221_8k.htm	8-K	25330
2	EXHIBIT 1.1	s105221_ex1-1.htm	EX-1.1	45790
3	EXHIBIT 4.1	s105221_ex4-1.htm	EX-4.1	95790
4	EXHIBIT 5.1	s105221_ex5-1.htm	EX-5.1	9380
5	EXHIBIT 10.1	s105221_ex10-1.htm	EX-10.1	260659
6	EXHIBIT 99.1	s105221_ex99-1.htm	EX-99.1	16177
7	GRAPHIC	pg01img1_ex1-1.jpg	GRAPHIC	18845
	Complete submission text file	0001615774-17-000348.txt		480506

Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103

Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080

HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)